These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8876864)

  • 1. Placebo response in anxiety disorders.
    Piercy MA; Sramek JJ; Kurtz NM; Cutler NR
    Ann Pharmacother; 1996 Sep; 30(9):1013-9. PubMed ID: 8876864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder.
    Huppert JD; Schultz LT; Foa EB; Barlow DH; Davidson JR; Gorman JM; Shear MK; Simpson HB; Woods SW
    Am J Psychiatry; 2004 Aug; 161(8):1485-7. PubMed ID: 15285978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo response in panic disorder.
    Coryell W; Noyes R
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo response in generalized anxiety: its effect on the outcome of clinical trials.
    Schweizer E; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():30-8. PubMed ID: 9363046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of placebo effects in pain treatment and research.
    Turner JA; Deyo RA; Loeser JD; Von Korff M; Fordyce WE
    JAMA; 1994 May; 271(20):1609-14. PubMed ID: 7880221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR; Glue P; Kolluri S; Emir B
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of placebo response during long-term treatment of panic disorder.
    Dager SR; Khan A; Cowley D; Avery DH; Elder J; Roy-Byrne P; Dunner DL
    Psychopharmacol Bull; 1990; 26(3):273-8. PubMed ID: 2274625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence.
    Mula M; Pini S; Cassano GB
    J Clin Psychopharmacol; 2007 Jun; 27(3):263-72. PubMed ID: 17502773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders.
    Cohen D; Consoli A; Bodeau N; Purper-Ouakil D; Deniau E; Guile JM; Donnelly C
    J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):39-47. PubMed ID: 20166795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early placebo response in anxious and depressed patients.
    Loebel AD; Hyde TS; Dunner DL
    J Clin Psychiatry; 1986 May; 47(5):230-3. PubMed ID: 3516977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential diagnosis of anxiety. Psychiatric and medical disorders.
    Cameron OG
    Psychiatr Clin North Am; 1985 Mar; 8(1):3-23. PubMed ID: 3887337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.
    Iovieno N; Papakostas GI
    J Clin Psychiatry; 2012 Oct; 73(10):1300-6. PubMed ID: 23140647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronicity, relapse, and illness--course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up.
    Yonkers KA; Bruce SE; Dyck IR; Keller MB
    Depress Anxiety; 2003; 17(3):173-9. PubMed ID: 12768651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gamma-aminobutyric acid in antipanic drug efficacy.
    Breslow MF; Fankhauser MP; Potter RL; Meredith KE; Misiaszek J; Hope DG
    Am J Psychiatry; 1989 Mar; 146(3):353-6. PubMed ID: 2537582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.